HHS regulatory agenda for 2021 is light on new proposed and final FDA rules
The impact of the coronavirus on the FDA’s work plans is evident in the latest semi-annual regulatory agenda for HHS, which includes only two new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
